Sedation Monitoring in ICU
- 格式:ppt
- 大小:2.61 MB
- 文档页数:36
中西医结合护理Chinese Journal of Integrative Nursing2023 年第 9 卷第 3 期Vol.9, No.3, 2023ICU 患者镇痛镇静的研究进展解雨秾(首都医科大学附属北京中医医院 重症医学科, 北京, 100010)摘要: 镇痛镇静对ICU 患者的身体、心理以及医疗安全均产生重要影响,ICU 患者治疗过程中的身心舒适情况受到更多人的关注。
本文就ICU 镇痛镇静的必要性、影响因素、常用药物、评估方法等进行总结,旨在为进一步提高ICU 患者诊疗舒适度提供参考。
关键词: ICU ; 镇静; 镇痛; 意识障碍; 评估工具中图分类号: R 473 文献标志码: A 文章编号: 2709-1961(2023)03-0014-04Progress of research on sedation andanalgesia in the ICUXIE Yunong(Department of Critical Care Medicine , Beijing Hospital of Traditional Chinese MedicineAffiliated to Capital Medical University , Beijing , 100010)ABSTRACT : Sedation and analgesia may influence the physical , psychological health and medi⁃cal safety of ICU patient. More concerns should be paid to physical and psychological comfort during the treatment in ICU. This paper summarized the importance , influencing factors , com⁃mon drugs , evaluation methods of sedation and analgesia in the ICU , and provided reference for improving patient comfort during diagnosis and treatment.KEY WORDS : ICU ; sedation ; analgesia ; disturbance of consciousness ; assessment tools重症监护室的患者通常会经历插管、创伤、护理等治疗行为,由此产生相应的身体痛苦和心理焦虑,病症严重与否是引发不良心理经历的关键因素,不良的心理经历可引发生理上的变化,甚至会产生比较严重的应激反应[1-3]。
DocumentationSTANDARDS AND GUIDELINESGuidelines for Documentation inthe Gastrointestinal Endoscopy SettingDisclaimerThe Society of Gastroenterology Nurses and Associates, Inc. assumes no responsibility for the practices or recommendations of any member or other practitioner, or for the policies and proceduresof any practice setting. The nurse and associate function within the limitations of licensure, statenurse practice act, and/or institutional policy.This guideline is based on current understanding and practice in the field. Eachgastrointestinal/endoscopy unit is responsible for establishing its own documentation proceduresand for creating its own forms, allowing for the differences in operation of each unit. The sampleforms illustrated herein are not necessarily suited for any unit other than the unit that developedeach form. They are printed here with the permission of the contributing facilities.PrefaceDocumentation development is guided by the use of the nursing process (assessment, planning, intervention and evaluation) to establish an individualized plan of care for the patient while in the endoscopy unit. This guideline is intended to provide direction for individual endoscopy units in establishing consistent patient care documentation. These documentation guidelines meet requirements for patients receiving sedation. A reduced requirement for documentation may apply dependent onyou institutional policy for non-sedated patients. Documentation should clearly and uniformly record details that closely describe situations or events occurring to patients undergoing endoscopy or related procedures. This guideline incorporates Centers for Medicare and Medicaid Services (CMS) requirements and Joint Commission on Accreditation of Healthcare Organizations (JCAHO) recommendations. Various members of the healthcare team may be responsible for documenting specific items in the patient record.In order to provide information that is easily adaptable to each patient care environment, theguideline is divided into three major components: Pre-Procedure, Procedure and Post-Procedure. The intent of the guideline and the accompanying outline is to provide information and criteria that canbe selected in formulating an individualized document that meets the needs and requirements to conform to institutional policy and to the particular endoscopy setting.Definition of TermsFor the purpose of this document, the following terms are defined:Vital signs: temperature, heart rate, respiratory rate, blood pressure, pain, and oxygen saturation assessment.DocumentationJCAHO: Joint Commission for Accreditation of Healthcare Organizations.CMS: Centers for Medicare and Medicaid Services.AAAHC: Accreditation Association for Ambulatory Health Care.Pre-Procedure Phase: the period of time prior to the beginning of the procedure.Procedure Phase: from the initiation of sedation and analgesia, when used, or the initial step of an invasive procedure, until completion of the diagnostic or therapeutic intervention.Post-Procedure Phase: from the completion of the diagnostic or therapeutic intervention until the patient leaves the facility.Section 1:Pre-Procedure PhaseAn age-specific patient assessment is performed and documented by a registered nurse. The assessment factors should include physical, psychosocial, current medications, treatment, and previous medical, anesthetic and drug history. Review of the patient’s symptoms and history will supply any pertinent information to be documented.All documentation should include time of performance and name of person performing the assessment or intervention. The frequency of the assessment is determined byinstitutional/departmental policy, the patient condition, the physician and/or the registered nurse. JCAHO recommendations and CMS requirements for the Pre-Procedure Phase are included in the following:1. Time of assessment2. Telemetry, if applicable.3. Oxygen saturation if sedation or analgesia is anticipated.4. CO2 monitoring (optional)5. Level of consciousness/mental status6. Disposition of patient valuables (i.e. glasses, jewelry,etc.)7. Baseline pain assessment using institutionally approved pain scale with identification ofarea, duration and type of pain8. Warmth, dryness and color of skin9. NPO status10. Bowel prep compliance (if applicable)11. Current medications and time of last dose(s) including aspirin, non-steroidal anti-inflammatory drugs, anticoagulants, sleeping medications, tranquilizers, over-the-counter drugs, herbal agents or illicit drugs.12. Allergies and reactions to medication, food, contrast or latex including OTC and herbals13. Presence of removable dental appliances, loose teeth, glasses/contact lenses, hearing aids14. Presence of prosthetic devices (e.g., hip replacement, valves)15. Airway assessment (e.g., jaw and neck mobility)16. Intravenous line: type, site, inserted by, rate of IV solution or presence of venous accessdevice17. Pregnancy status18. Physical assessment appropriate to the patient’s age, individual needs, and procedure to beperformed19. Labs or previous procedures results (if applicable)Documentation20. Patient concerns21. Emotional status, psychological, spiritual, cultural status22. Assessment for potential abuse23. Educational needs assessment with identification of barriers to learning24. Known significant medical diagnoses and conditions including current status of infectiousdisease/exposure, physical disabilities, and conditions25. Known significant surgical and invasive procedures, history of complications or reactions toprevious sedation, analgesia, or general anesthesia26. Validation of correct patient/correct procedure27. Admitting registered nurse signature/timeSection 2:Procedure PhaseEvery patient undergoing a diagnostic or therapeutic, or invasive procedure requires monitoring by a registered nurse or other qualified personnel. Whatever method is employed, documentation should include event, intervention (if necessary) and outcome. Each facility must comply with applicable regulations and guidelines, including state regulations, JCAHO guidelines, CMS requirements, andthe facility’s standards for monitoring of patients. JCAHO recommendations and CMS requirements forthe Procedure Phase are included in the following:1. Vital signs2. Telemetry, if applicable3. Baseline and ongoing pulse oximetry is required for patients undergoing sedation andanalgesia.4. CO² (optional)5. Level of consciousness/mental status6. Continuous pain assessment using institutional approved pain scale with documentedresponse to intervention7. Warmth, dryness, and color of skin8. Procedure(s) performed9. Physician(s), registered nurse(s) and support staff involved in the procedure10. Name and dosage of all drugs and agents used (including oxygen), time, route ofadministration, by whom, and patient’s response11. Type and amount of all fluids administered (including blood and blood products)12. Equipment/accessories used (i.e. cautery, laser,etc.)13. Implantable devices (i.e.stents, tubes, etc.)14. Unusual events, interventions and outcomes15. Patient status at the end of procedure16. Type of specimen(s) obtained and disposition17. Post-Procedure findings18. Signature(s) required19. “Time Out” initiated by the physician to confirm the right patient/right procedureDocumentationSection 3:Post-Procedure PhaseThe frequency of the assessment is determined by institutional/departmental policy, the physician and/or the registered nurse. JCAHO recommendations and CMS requirements for the Post-Procedure Phase are included in the following:1. Time of arrival in post-procedure area2. Vital signs3. Pulse oximetry is required until return to pre-procedure baseline for patients who receivedsedation and analgesia.4. Continuous pain assessment using institutional approved pain scale with documentedresponse to intervention5. Level of consciousness/mental status6. Warmth, dryness and color of skin7. Name and dosage of all drugs used (including oxygen), time, route of administration, bywhom, and patient’s response8. IV fluids administered and/or discontinued including blood and blood products9. Unusual events, interventions, and outcomes10. Physical assessment appropriate to age, patient needs, and procedure performed11. Disposition of patient (hospital room, home, x-ray, etc.), and with whom12. Report given to subsequent caregiver13. Mode of transportation (ambulatory, stretcher, wheelchair, etc.)14. Name of person responsible for outpatient at discharge15. Age specific discharge instructions and educational materials given to outpatient and/oraccompanying adult, who verbalizes or demonstrates understanding and signs form.16. Discharge criteria applied17. Time of discharge18. Signature of discharge nurse19. Discharge instructions per institution policy to include follow-up and specific patient orderswritten by the physician.ConclusionBy combining the JCAHO recommendations and CMS requirements for documentation along with published data and input gathered from the membership, SGNA anticipates that these recommendations will provide guidance to each endoscopy unit staff in establishing a comprehensive institutional documentation policy.ReferencesAmerican Society of Anesthesiologists. (2001). Updated practice guidelines for sedation and analgesia by non-anesthesiologists. [Practice guideline]. Park Ridge, IL: Author.Documentation Committee on Drugs of the American Academy of Pediatrics. (1992). Guidelines for monitoring and management of pediatric patients during and after sedation for diagnostic and therapeuticprocedures. Pediatrics, 89, 1110-1115.Health Care Finance Administration. (1993). Generic Quality Screen Guidelines, Exhibit 37.Washington, DC: Author.Joint Commission on Accreditation of Healthcare Organizations. (2003). Comprehensive Accreditation Manual for Hospitals: The Official Handbook. Oakbrook Terrace, IL:Author.Kost, M. (1999). Conscious sedation: Guarding your patient against complications. Nursing. 29 (4): 34-39.Standards of Practice Committee of the American Society for Gastrointestinal Endoscopy. (2002).Sedation and monitoring of patients undergoing gastrointestinal endoscopic procedures.Gastrointestinal Endoscopy, 2, 626-629.Society of Gastroenterology Nurses and Associates, Inc. (2000). Guidelines for nursing care of the patient receiving sedation and analgesia in the gastrointestinal setting. [Guideline].Gastroenterology Nursing. 23:125-129.AcknowledgmentsFirst edition 1989, revised 2003.Prepared by the Education Committee of the Society of Gastroenterology Nurses and Associates, Inc. (SGNA) chaired by Trina Van Guilder, RN,BSN,CGRN.Adopted by the Society of Gastroenterology Nurses and Associates, Inc. Board of Directors 2003. Published as a service to members by the Society of Gastroenterology Nurses and Associates, Inc. Copyright © 2003, Society of Gastroenterology Nurses and Associates, Inc.DocumentationOutline for Form PreparationThe following outline is included to ease the preparation of a form to be used for the acquisition of data, procedure and post-procedure documentation and statement of patient’s dispositionI.Pre-Procedure PhaseScheduled ProcedureB. Patient identification1. Demographic dataa. Nameb. Date of birthc. Unique patient identification numberd. Phone number2. Physician3. Referring physician4. Time of arrival5. Communication barrier6. Impairments7. Responsible adult fordischarge/accompanied byC. Health History1. Past procedure(s)2. Previous problems with anesthesia orsedation3. Chief complaint4. Present illness5. Allergies including reactions: food,medication, latex6. Current medication, time of last dose(s)7. Level of consciousness/ mental status8. Level of comfort9. Bowel preparation10. NPO status11. Baseline vital signs and pulse oximetry12. Weight in pounds/kilogramsAirway assessment (neck and jaw mobility, dentition)D. Medical History1. Heart disease, pacemaker, implantedcardioverter defibrillator, dysrhythmias,valvular heart disease2. Hypertension3. Lung/breathing problems (e.g., asthma,COPD, sleep apnea)4. Liver disease (e.g., jaundice, hepatitis,cirrhosis)5. Pancreatic disorders (e.g., pancreatitis,6. rders (e.g., seizures,disease10.nia, IBD/IBS, diverticulosis,13.sing institutional scale, duration, location)rE. Surgisthetic devices (e.g.,stents, valves, joint replacements)sF. Family Historycancer2. olyps3. IBDdiabetes)Neurological disoCVA, ALS, MS)7. Kidney8. CancerBleeding or blood di9. sorders, includingtransfusion historyGI problems (e.g., peptic ulcer disease,hiatal herpolyps)11. Arthritis12. Pregnancy statusGlaucoma14. Pain (u15. Othecal1. Implanted pro2. GI surgerie1. ColonPDocumentationG. Social Historye.g., ETOH, illicitrugs)H. Venous Access Devicee used Solution and rate/flushResultsJ. P 4. Methods (e.g., pamphlet, video) gM. Presence and Disposition of Appliances(e.g., dentures, hearing aids, contacts,. Vulnerable Adult yes/no; Social Servicesgnaturease 1. Substance abuse (d 2. Smoking history1. Time started2. Site3. Type of devic . 45. Inserted by I. Laboratory Test atient Teaching1. Patient knowledge of procedure2. Barriers to learning3. Interventions to learning barriers 5. Demonstrates understandin K. Pre-Procedure Nursing NotesL. Informed Consent Obtainedglasses) N Notified yes/noO. Admitting Nurse SiII. Procedure PhProcedure TimeB. Validation of correct patient/correct e (“Time out”)B. S rse(s) Support staffC. Medication (including oxygen)ed Administered by response D. V ns of skin Level of consciousness/mental status sponse E. E 3. The dingin condition c. : settings,e. evice: purpose (e.g.,ding tubes: size,, lot number Dilators: size, type 4. amples). Documentation of anyindwelling devices left in patientStarted Completedprocedur taffPhysician(s)Registered nu Technicians1. Time administer2. Dosage/liters3. Route/method . 45. Patientital Signs1. Blood pressure, heart rate, respiratio2. Oxygen saturation3. Warmth, color and dryness . 45. Level of comfort/requipment/Accessories1. Endoscope2. Monitoring equipmentrapeutic modalities (examples)a. Cautery: type, setting, groun pad site & pre/post skb. Laser: type, settings, safetyprocedures followedArgon plasma coagulator flow rate, grounding pad site &pre/post skin conditiond. Band ligators: number placed Injection d sclerotherapy, tattooing, contrast medium)f. PEG/PEJ, stents, fee type, manufacturer . g h. Other (e.g., snare)Diagnostic modalities (ex a. Probes (e.g, pH, rectal) b. Manometry catheterc. Other (e.g., biopsy forceps)dDocumentation. FluoroscopyG. Imaging(e.g., videotape, photography)H. S y icrobiology Procedure Performed and Post-ProcedureJ. Nursing Observation Notestions andre3. ost-procedure assessment beforeK. Nurse/Staff Signature(s)F 1. Time 1. Methodpecimens1. Biopsy2. Cytolog3. M4. OtherI.Diagnosis 1. Unusual events, interven outcomes2. Toleration of procedu P transfer to recoveryPhysician’s signatureIII. Post-Procedure PhaseA. Time of Arrival to Post-Procedure Area. Vital Signs and oxygen saturation fortal Status t/ResponseE. Ven d (including bloodts) Time discontinued 3. Condition of siteB patients who received sedationC. Level of Consciousness/MenD. Level of Comfor ous Access1. Total amount infuse and blood produc . 2 F. Medications1. Time administered2. Dosage3. Route4. Administered by5. Patient responseNote: Usage of only acceptable medication names and dosage abbreviations.G. Oral Fluid ToleranceH. Report Given to Subsequent CaregiverI. Discharge InstructionsGiven by Given toVerbalizes or demonstrates understanding Signature of patient and/or accompanyingadultDischarged according to criteria or byphysician discharge orderJ. DispositionDestinationAccompanied by (name of individual) Mode of transportationK. Time of DischargeL. Nursing Observation NotesUnusual events, interventions and outcomesM. Discharge Nurse SignatureDischarge Instructions to OutpatientsA. Type of Procedure PerformedB. Activity1. Normal2. Restrictions (e.g., driving, operatingmachinery, working)C. DietNormalModificationsa. Special diet instructionsDocumentationF. Medication Instructionsb. Fluids Restrictions NPO (e.g., untilanesthetic worn off)1. Continue2. DiscontinueAvoidance of alcohol (state number ofhours)3. New medications prescribed4. Interactions of medications with foodand other drugs D. Post-Procedure Complication Symptoms 1. List symptoms specifically (e.g.,abdominal pain, fever, evidence of bleeding)G. Specimen ResultsMethod for obtaining results (e.g., callphysician’s office)2. Instructions for notifying physician orobtaining emergency assistance (include physician office/answering service phone numbers) H. Additional Pertinent InstructionsFollow-up visit with physician Referrals, if appropriateE. Instructions for Symptoms and SensationsExpected as Normal, and RemediesSore throat - throat lozenges, gargle withwarm water, etc.Redness at IV site - apply warm compress,etc.Gaseous discomfort - belching, passingflatusI. Signatures1. Patient and/or accompanying adult2. Nurse discharging the patientA copy of the discharge instructions or written documentation is given to the patient and one is kept in the patient’s chart.。
甘肃医药2020年39卷第12期Gansu Medical Journal ,2020,Vol.39,No.12图1ICU 程序化镇静镇痛流程图镇痛镇静可使患者处于舒适状态[1],“过度”与不足可引诱发呼吸机相关肺炎(ventilator associated pne-umonia ,VAP )从而增加非计划拔管(unplanned extuba -tion ,UE )风险[2]。
程序化镇痛镇静(procedural sedationand analgesia ,PSA )是一种系统性镇痛方法,包括方案和目标制定、监测评估、每日唤醒和撤离4个环节[3],但PSA 在我国并未得到有效实施[4]。
2013年以来,我科将医护一体化合作模式应用于ICU 镇痛镇静安全管理,并取得满意效果,报道如下。
1对象与方法1.1研究对象选取2016年1月至2017年12月我院ICU 实施医护一体化合作模式前收治的1085例患者,其中男性589例,女性496例;年龄18~80岁,平均(58.6±11.8)岁。
选取2018年1月至2019年12月,我院ICU 实施医护一体化合作模式后收治的941例患者,其中男性507例,女性434例;年龄18~80岁,平均(59.8±12.7)岁。
两组一般资料比较无统计学差异(P >0.05),具有可比性。
1.2方法1.2.1成立镇痛镇静质量控制小组(QC 小组)。
ICU 护士长担任组长,成员包括5名医师和5名护士。
制定管理标准,管理目标为“3C ”,即患者安静(calm )、舒适(comfortable )及合作(collaboration );实施流程详见图1;沟通方法为标准化沟通模式(SBAR );质量改进用根因分析法;护理不良事件网络上报。
医护一体化合作模式在ICU 镇痛镇静管理中的效果陈艳茂名市中医院,广东茂名525000【摘要】目的:探讨医护一体化合作模式在ICU 镇静镇痛管理中的应用及效果。
RASS评分表的解读及常用镇静药物的临床应用一、Richmond镇静躁动评分(RASS)注:2013年美国危重病医学会镇静、镇痛和谵妄指南指出:1、躁动镇静评分(Richmond Agitation-Sedation Scale,RASS )和镇静躁动评分(Sedation Agitation Scale, SAS)是评估成年ICU患者镇静质量与深度最为有效和可靠的工具。
2、对于未昏迷且未接受肌松治疗的成年危重病患者,反对采用脑功能的客观评估指标(如听觉诱发电位[AEPs]、脑电双频指数[BIS]、麻醉趋势指数[NIl]、患者状态指数[PSI]及状态熵[SE]等)做为镇静深度的主要监测方法,这是由于这些监测手段尚不足以替代主观镇静评分系统。
3、浅镇静的意义:(1)对于成年ICU患者维持轻度镇静可以改善临床预后,如缩短机械通气时间及ICU住院日。
(2)维持轻度镇静增加生理应激反应,但并不增加心肌缺血的发生率。
(3)轻度镇静成为镇静目标,浅镇静可以减少ICU住院日。
(镇痛镇静治疗的ABCDE——浅而有效:A wakening(神智)可唤醒B reathing 主动呼吸C oordination, Choice合作抉择能力D elirium monitoring/ management监测并处理谵妄E arly mobility and Exercise早期活动与功能锻炼)二、RASS评估步骤三、文献1、早期目标导向镇静下不同镇静药物对谵妄发生的影响【摘要】目的研究在早期目标导向镇静策略下,右美托咪定、咪达唑仑、丙泊酚三种药物对谵妄发生的影响。
方法选取川北医学院附属医院重症医学科需要接受镇静治疗的患者100 例(2016 年1 月至2017 年6 月),随机分配接受右美托咪定(A 组)、咪达唑仑(B 组)、丙泊酚(C 组)镇静治疗。
躁动镇静评分量表评估各组镇静的水平,以达到躁动镇静评分-2 ~+1 分镇静目标。
Advances in Clinical Medicine 临床医学进展, 2023, 13(10), 15484-15488Published Online October 2023 in Hans. https:///journal/acmhttps:///10.12677/acm.2023.13102166ICU镇静药物新进展——注射用甲磺酸瑞马唑仑姜杉大连医科大学研究生院,辽宁大连收稿日期:2023年8月28日;录用日期:2023年9月21日;发布日期:2023年10月8日摘要瑞马唑仑是新型苯二氮卓类药物,具有超效性、水溶性,通过非特异性酯酶快速代谢,代谢物几乎不具备药理活性,可被氟马西尼快速逆转,镇静成功率高,镇静深度可调控,低血压等不良反应少,且可抑制细胞因子分泌和通过调节细胞增殖来影响免疫细胞功能。
关键词瑞马唑仑,镇静药,ICU,不良反应New Progress of Sedatives in ICU—Remimazolam Mesylate for InjectionShan JiangGraduate School of Dalian Medical University, Dalian LiaoningReceived: Aug. 28th, 2023; accepted: Sep. 21st, 2023; published: Oct. 8th, 2023AbstractRemimazolam is a new benzadverse effectdiazepine drug, which is super-effective and water-soluble.It is rapidly metabolized by non-specific esterase, and its metabolites have almost no pharmaco-logical activity. It can be quickly reversed by Masini fluoride, with high sedation success rate, ad-justable sedation depth and few adverse reactions such as hypotension, and can inhibit cytokine secretion and affect immune cell function by regulating cell proliferation.KeywordsRemimazolam, Sedative, ICU, Adverse Effect姜杉Copyright © 2023 by author(s) and Hans Publishers Inc.This work is licensed under the Creative Commons Attribution International License (CC BY 4.0)./licenses/by/4.0/1. 引言ICU患者治疗的重要部分是镇静与镇痛。
西医重症医学科术语英文翻译以下是常见的西医重症医学科术语英文翻译:1. 重症医学科:Intensive Care Unit (ICU)2. 急性呼吸窘迫综合征:Acute Respiratory Distress Syndrome (ARDS)3. 慢性阻塞性肺疾病:Chronic Obstructive Pulmonary Disease (COPD)4. 心力衰竭:Heart Failure (HF)5. 急性心肌梗死:Acute Myocardial Infarction (AMI)6. 休克:Shock7. 重症感染:Severe Infections8. 多器官功能衰竭:Multiple Organ Dysfunction Syndrome (MODS)9. 脓毒症:Sepsis10. 深静脉血栓形成:Deep Vein Thrombosis (DVT)11. 重症哮喘:Severe Asthma12. 急性肾损伤:Acute Kidney Injury (AKI)13. 重症胰腺炎:Severe Pancreatitis14. 重症肝炎:Severe Hepatitis15. 严重烧伤:Major Burns16. 大出血:Massive Bleeding17. 危重病营养支持:Critical Care Nutrition Support18. 机械通气:Mechanical Ventilation19. 血液净化治疗:Blood Purification Therapies20. 心肺复苏术:Cardiopulmonary Resuscitation (CPR)21. 体外膜氧合技术:Extracorporeal Membrane Oxygenation (ECMO)22. 重症监测技术:Critical Care Monitoring Techniques23. 血管活性药物:Vasoactive Drugs24. 镇静镇痛治疗:Sedation and Analgesia Therapies25. 重症患者的转运:Transport of Critically Ill Patients26. 重症护理记录:Intensive Care Unit (ICU) Notes and Progress Notes27. 脓毒症管理:Sepsis Management28. 多学科团队协作:Multidisciplinary Team Collaborations in the ICU29. 重症患者的心理护理:Psychological Care for the Critically Ill30. 人工气道管理:Artificial Airway Management in the ICU31. 高血压危象管理:Management of Hypertensive Crises in the ICU32. 心律失常处理:Treatment of Arrhythmias in the ICU33. 急性呼吸衰竭处理:Treatment of Acute Respiratory Failure in the ICU34. 血液保护和输血治疗:Blood Conservation and Transfusion Therapies in the ICU35. 水、电解质平衡和酸碱平衡紊乱的处理:Management of Fluid, Electrolyte, and Acid-Base Disorders in the ICU36. 重症患者的血糖管理:Glycemic Control in the ICU37. 中性粒细胞减少症的处理:Management of Neutropenia in the ICU38. 重症患者的营养支持原则与实践:Principles and Practice of Nutrition Support in the ICU39. 重症患者的疼痛管理:Pain Management in the ICU40. 镇静和镇痛的伦理问题与考虑因素:Ethical Issues and Considerations in Sedation andAnalgesia in the ICU41. 多器官功能衰竭的预防与管理:Prevention and Management of Multiple Organ Dysfunction Syndrome (MODS) in the ICU42. 重症患者的机械通气管理策略与实践:Strategies and Practice of Mechanical Ventilation Management in the ICU43. 重症患者的人工气道管理原则与实践:Principles and Practice of Artificial Airway Management in the ICU44. 高血压危象的诊断与治疗策略:Diagnostic and Therapeutic Strategies for Hypertensive Crises in the ICU45. 心律失常的评估与处理原则:Assessment and Management Principles for Arrhythmias in the ICU46. 急性呼吸衰竭的诊断与治疗策略:Diagnostic and Therapeutic Strategies for Acute Respiratory Failure in the ICU47. 水、电解质平衡和酸碱平衡紊乱的诊断与处理原则:Diagnostic and Management Principles for Fluid, Electrolyte, and Acid-Base Disorders in the ICU48. 重症患者的血糖监测与管理策略:Monitoring and Management Strategies for Glycemia in the ICU49. 重症患者的心理护理与精神支持原则与实践:Principles and Practice of Psychological Care and Mental Support for the Critically Ill。
2014版静疗规范指南英文回答:2014 Edition of the Standards of Practice for Sedation.The 2014 edition of the Standards of Practice for Sedation provides guidance for the safe and effective use of sedation in various healthcare settings. It outlines the principles of sedation, including the assessment of patients, the monitoring and management of sedation, and the recovery from sedation.The Standards of Practice for Sedation are developed by the American Society of Anesthesiologists (ASA) and represent the consensus of experts in the field. They are intended to be used by healthcare professionals who administer or manage sedation, including anesthesiologists, surgeons, dentists, nurses, and other qualified practitioners.The 2014 edition of the Standards of Practice for Sedation includes several key updates, including:Clarification of the definitions of sedation and analgesia.New recommendations for the assessment of patients before sedation.Updated guidelines for the monitoring and management of sedation.New guidance on the recovery from sedation.The Standards of Practice for Sedation are an essential resource for healthcare professionals who administer or manage sedation. They provide guidance on the safe and effective use of sedation, and help to ensure the safety and well-being of patients.中文回答:2014版静疗规范指南。
Ramsay镇静评分法在ICU血液净化患者中的应用评价目的探讨Ramsay镇静评分法在ICU血液净化患者中的应用效果。
方法选择2013年1月~2014年1月在ICU收治的血液净化的患者80例,随机分为观察组和对照组各40例,观察组为应用Ramsay镇静评分法进行镇静评估,并根据评估结果调整镇静给药护理方案。
对照组为靠经验观察进行镇静给药护理方案。
比较两组患者血液净化的指标:堵管贴壁引血不畅、动脉压报警、脱管、破膜、提前换管时间、患者不配合等,以及镇静药用后并发症发生率如低血压、血氧饱和度下降等。
结果观察组血液净化不良的各项指标:堵管贴壁引血不畅、动脉压报警、脱管、提前换管时间、患者不配合等发生率较对照组减少(P<0.05),镇静药用后并发症发生率如血压下降、呼吸抑制较对照组减少(P<0.05)。
结论应用Ramsay镇静评分法监测ICU血液净化患者的镇静效果,可有效减少血液净化并发症的发生率,确保血液净化治疗技术顺利进行。
[Abstract] Objective To investigate the Ramsay sedation score method,application effect of blood purification in ICU patients. Methods From January 2013 to January 2014 patients admitted in the ICU of blood purification of 80 cases were randomly divided into observation group and control group 40 cases,observation group for Ramsay sedation score method was used to calm assessment,and adjust the calm to medicine nursing plan according to the evaluation results.The control group to observe the sedation by experience to medicine nursing care pare two groups of patients’ blood purifica tion indexes blocking pipe sticking wall and arterial blood pressure alarm and to take off the tube,rupture,ahead of time of the tube,patients don’t cooperate,etc.as well as the calm after the medicinal complications such as low blood pressure,blood oxygen desaturation. Results Observation group each index of blood purification blocking pipe sticking wall led not free,arterial blood pressure alarm,take off the tube and tube exchanger ahead of time,patients don’t cooperate rate less than the control group (P<0.05),composed of medicinal complications such as blood pressure to drop,after respiratory depression were less than the control group (P<0.05). Conclusion Application of Ramsay sedation score method of monitoring the efficacy of blood purification in the ICU patients sedation,the incidence of complications can effectively reduce blood purification,to ensure that blood purification treatment technology.[Key words] Calm;Intensive care;Blood purification重症监护室(intensive care unit,ICU)血液净化是治疗危重患者常用的手段之一[1],持续血液净化(continuous blood purification,CBP)过程中患者躁动会造成很大危害,使血液净化并发症的发生率增多,严重影响患者的预后,增加了治疗费用和医务人员的工作量,造成CBP治疗效率下降,严重者甚至被迫停止治疗[2]。